Obscure gastrointestinal bleeding: Rebleeding rates and rebleeding predictors found

Posted by Michael Jannicelli | Apr 7, 2023 | Uncategorized | 0 |

Researchers conducted a large-scale clinical study to identify long-term rebleeding rates and predictors of rebleeding after capsule endoscopy (CE) in patients with obscure gastrointestinal bleeding (OGIB). The results revealed that the overall cumulative rebleeding rate in the five years after CE was as high as 41.7%, and they also suggested the need for particularly careful follow-up in patients with liver cirrhosis, those taking anticoagulants, or those with previous massive bleeding. The study offers an important finding in considering the long-term follow-up regarding OGIB, and might contribute to future clinical guidelines for OGIB treatment.

About The Author

Michael Jannicelli

Michael Jannicelli - "A PROVEN BUSINESS FIRESTARTER & BRANDING GENIUS" a true natural born Trendsetter. • Created over 100 products under 3 brands, sold in 30+ countries worldwide and influencing youth across the globe. • Featured in Forbes magazine +over 100 print publications, television talk shows, major motion pictures and national radio stations. • Co-founder and VP of Bliss beverage USA and President/co-founder of Socko International - fastest growing privately held beverage company in US (Forbes) with Hogan Energy & Raw Energy WWE. • Co-founder of Throwdown Industries (2003) - leading brand in multibillion dollar Impact/Action Sports Market (products designed for superior MN • Diagnosed with auto-immune diseases aged 13; using his experience to help others and promote a positive message while developing edgy products to benefit people with chronic illness.